SMARCA1 and cancer: Through the comprehensive analysis, we discovered that SMARCA1 had good diagnostic performance on 29 cancers, especially on OV (AUC = 0.981), LAML (AUC = 0.935), DLBC (AUC = 0.970), CESC (AUC = 0.846), READ (AUC = 0.802), COAD (AUC = 0.807), LGG (AUC = 0.938), THYM (AUC = 0.992), PAAD (AUC = 0.898), GBM (AUC = 0.838) and TGCT (AUC = 0.910) (S5 Fig).